Abstract:Technological advances and high-throughput bio-chemical assays are rapidly changing ways how we formulate and test biological hypotheses, and how we treat patients. Most complex diseases arise on a background of genetics, lifestyle and environment factors, and manifest themselves as a spectrum of symptoms. To fathom intricate biological processes and their changes from healthy to disease states, we need to systematically integrate and analyze multi-omics datasets, ontologies, and diverse annotations. Without proper management of such complex biological and clinical data, artificial intelligence (AI) algorithms alone cannot be effectively trained, validated, and successfully applied to provide trustworthy and patient-centric diagnosis, prognosis and treatment. Precision medicine requires to use multi-omics approaches effectively, and offers many opportunities for using AI, "big data" analytics, and integrative computational biology workflows. Advances in optical and biochemical assay technologies including sequencing, mass spectrometry and imaging modalities have transformed research by empowering us to simultaneously view all genes expressed, identify proteome-wide changes, and assess interacting partners of each individual protein within a dynamically changing biological system, at an individual cell level. While such views are already having an impact on our understanding of healthy and disease conditions, it remains challenging to extract useful information comprehensively and systematically from individual studies, ensure that signal is separated from noise, develop models, and provide hypotheses for further research. Data remain incomplete and are often poorly connected using fragmented biological networks. In addition, statistical and machine learning models are developed at a cohort level and often not validated at the individual patient level. Combining integrative computational biology and AI has the potential to improve understanding and treatment of diseases by identifying biomarkers and building explainable models characterizing individual patients. From systematic data analysis to more specific diagnostic, prognostic and predictive biomarkers, drug mechanism of action, and patient selection, such analyses influence multiple steps from prevention to disease characterization, and from prognosis to drug discovery. Data mining, machine learning, graph theory and advanced visualization may help identify diagnostic, prognostic and predictive biomarkers, and create causal models of disease. Intertwining computational prediction and modeling with biological experiments leads to faster, more biologically and clinically relevant discoveries. However, computational analysis results and models are going to be only as accurate and useful as correct and comprehensive are the networks, ontologies and datasets used to build them. High quality, curated data portals provide the necessary foundation for translational research. They help to identify better biomarkers, new drugs, precision treatments, and should lead to improved patient outcomes and their quality of life. Intertwining computational prediction and modeling with biological experiments, efficiently and effectively leads to more useful findings faster.

Confounder control in biomedicine necessitates conceptual considerations beyond statistical evaluations

Correct deconfounding enables causal machine learning for precision medicine and beyond

Gaining Confidence on Molecular Classification Through Consensus Modeling and Validation

Using permutations to assess confounding in machine learning applications for digital health

Measuring the effects of confounders in medical supervised classification problems: the Confounding Index (CI)

Learning Personalized Treatment Decisions in Precision Medicine: Disentangling Treatment Assignment Bias in Counterfactual Outcome Prediction and Biomarker Identification

Confound-leakage: Confound Removal in Machine Learning Leads to Leakage

Causal Inference and Counterfactual Prediction in Machine Learning for Actionable Healthcare

Statistical Thinking, Machine Learning

Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance

Buyer Beware: confounding factors and biases abound when predicting omics-based biomarkers from histological images

High-dimensional confounding in causal mediation: a comparison study of double machine learning and regularized partial correlation network

Double machine learning and automated confounder selection: A cautionary tale

A giant with feet of clay: on the validity of the data that feed machine learning in medicine

Reliable machine learning models in genomic medicine using conformal prediction

Uncovering interpretable potential confounders in electronic medical records

Evaluating Machine Learning Models against Clinical Protocols for Enhanced Interpretability and Continuity of Care

The Future will be Different than Today: Model Evaluation Considerations when Developing Translational Clinical Biomarker

Monitoring machine learning (ML)-based risk prediction algorithms in the presence of confounding medical interventions

Machine Learning in Modeling Disease Trajectory and Treatment Outcomes: An Emerging Enabler for Model‐Informed Precision Medicine

Explainable biology for improved therapies in precision medicine: AI is not enough